Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-12

FDA Approved: VIGABATRIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin from Aurobindo Pharma Limited under an ANDA, granting approval for a generic form of the drug. This expan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)